Plethysmograph Market: Current Analysis and Forecast (2023-2030)

A plethysmograph is a medical device used to measure changes in volume within an organ or a whole body part. It's often used in respiratory physiology to measure changes in air volume in the lungs. This device can help diagnose respiratory conditions and assess lung function. Several other factors, such as the rising geriatric population, and unhealthy lifestyles are leading drivers of plethysmographs globally. For instance, according to the BMC Public Health, in July 2023, the prevalence of unhealthy lifestyles was 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for physical activity, 42.3% for screen time, and 63.9% for sleep duration.

The Plethysmograph Market is expected to grow at a steady rate of around 4.5% owing to the increased prevalence of alcohol and tobacco globally. According to the 2021 National Survey on Drug Use and Health (NSDUH), 29.5 million people ages 12 and older had Alcohol Use Disorder (AUD) in the year 2020. Several factors, including a rising prevalence of respiratory disorders, increasing awareness regarding throat cancer, increasing smoking population, rising alcoholism culture, and increased investments in healthcare departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with plethysmograph has resulted in faster treatment procedures and better accuracy which is also driving this market of plethysmograph at a steady rate.

Based on product type, the market is segmented into body plethysmograph, limbs plethysmograph, and others. The limb plethysmograph segment held the maximum share in the global market of plethysmographs in 2022 owing to its efficiency in detecting blockage in arms and legs. It detects differences between the pulses and if there is a decrease in the pulse between the arm and leg, it may indicate a blockage. This segment dominated the market because of the increasing geriatric population, and increased prevalence of ill lifestyles including smoking, alcoholism, and unhealthy lifestyles among people. Thus, the limb plethysmograph segment held a significant share of the market in 2022.

Based on end use, the market is segmented into hospitals, clinics, and others. The clinics held a significant share of the market in 2022. Clinics serve as primary healthcare institutions where patients receive an immediate diagnosis, treatment, and ongoing care. They play a pivotal role in the management of patients by providing state-of-the-art medical facilities, specialized expertise, and a multidisciplinary approach to patient care. Rising collaborations and acquisitions are boosting this segment's growth. Hence, the clinics category is expected to witness higher CAGR during the forecast period.

For a better understanding of the market adoption of plethysmograph, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing smoke pollution, increasing alcohol consumption, and rising number of investments in developing effective plethysmograph. For example, according to the National Center for Drug Abuse Statistics, in a Johns Hopkins-University of Maryland-Baltimore survey, 60.1% of participants reported drinking more alcohol after March 1, 2020. Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include ACI Medical, LLC; COSMED srl; D. E. Hokanson Inc.; Geratherm Medical AG; medical equipment europe GmbH; Medizinische Messtechnik GmbH; MGC Diagnostics Corporation; Morgan Scientific; PulmOne Advanced Medical Devices; SCHILLER AG.